Express Scripts Holding Company Company Profile (NASDAQ:ESRX)

About Express Scripts Holding Company (NASDAQ:ESRX)

Express Scripts Holding Company logoExpress Scripts, Inc. is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM). PBM segment’s services include retail network pharmacy management and retail drug card programs, home delivery services, specialty benefit services, patient care contact centers, benefit plan design and consultation, drug formulary management, compliance and therapy management programs, information reporting and analysis programs, rebate programs, and electronic claims processing and drug utilization review. EM segment’s services include distribution of pharmaceuticals and medical supplies to providers and clinics and healthcare account administration and implementation of consumer-directed healthcare solutions.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Health Care Plans
  • Sub-Industry: Health Care Services
  • Symbol: NASDAQ:ESRX
  • CUSIP: 30219G10
  • Web: www.express-scripts.com
Capitalization:
  • Market Cap: $32.81056 billion
  • Outstanding Shares: 577,549,000
Average Prices:
  • 50 Day Moving Avg: $61.90
  • 200 Day Moving Avg: $62.41
  • 52 Week Range: $56.62 - $77.50
P/E:
  • Trailing P/E Ratio: 9.93
  • Foreward P/E Ratio: 7.48
  • P/E Growth: 0.67
Sales & Book Value:
  • Annual Revenue: $100.28 billion
  • Price / Sales: 0.33
  • Book Value: $27.26 per share
  • Price / Book: 2.10
Profitability:
  • EBITDA: $7.16 billion
  • Net Margins: 3.50%
  • Return on Equity: 25.58%
  • Return on Assets: 7.96%
Debt:
  • Debt-to-Equity Ratio: 0.88%
  • Current Ratio: 0.69%
  • Quick Ratio: 0.58%
Misc:
  • Average Volume: 3.25 million shs.
  • Beta: 0.88
  • Short Ratio: 9.82
 

Frequently Asked Questions for Express Scripts Holding Company (NASDAQ:ESRX)

What is Express Scripts Holding Company's stock symbol?

Express Scripts Holding Company trades on the NASDAQ under the ticker symbol "ESRX."

How were Express Scripts Holding Company's earnings last quarter?

Express Scripts Holding Company (NASDAQ:ESRX) issued its quarterly earnings data on Tuesday, July, 25th. The company reported $1.73 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.71 by $0.02. The business had revenue of $25.35 billion for the quarter, compared to the consensus estimate of $25.52 billion. Express Scripts Holding Company had a net margin of 3.50% and a return on equity of 25.58%. The company's quarterly revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.57 EPS. View Express Scripts Holding Company's Earnings History.

When will Express Scripts Holding Company make its next earnings announcement?

Express Scripts Holding Company is scheduled to release their next quarterly earnings announcement on Tuesday, October, 24th 2017. View Earnings Estimates for Express Scripts Holding Company.

What guidance has Express Scripts Holding Company issued on next quarter's earnings?

Express Scripts Holding Company updated its FY17 earnings guidance on Tuesday, July, 25th. The company provided EPS guidance of $6.95-7.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.97. Express Scripts Holding Company also updated its Q3 guidance to $1.88-1.92 EPS.

Where is Express Scripts Holding Company's stock going? Where will Express Scripts Holding Company's stock price be in 2017?

20 analysts have issued 12-month target prices for Express Scripts Holding Company's shares. Their predictions range from $56.00 to $85.00. On average, they anticipate Express Scripts Holding Company's share price to reach $68.50 in the next twelve months. View Analyst Ratings for Express Scripts Holding Company.

What are analysts saying about Express Scripts Holding Company stock?

Here are some recent quotes from research analysts about Express Scripts Holding Company stock:

  • 1. According to Zacks Investment Research, "We are upbeat about Express Scripts’ pharmacy-benefits management long-term outlook. The projection takes the volatile healthcare market trends, inflation, patent expiration and lower industry utilization growth into consideration. Furthermore, Express Scripts should benefit from increased generic utilization, shift toward mail orders, strong specialty growth and an aging population. Branded drugs are becoming increasingly expensive due to double-digit brand inflation. Thus, continued rise in the price of specialty drugs and overwhelming regulatory burden is opening up considerable prospects for generics. However, over the past one year, Express Scripts has underperformed the broader industry in terms of price. Tough competition in the niche space and the persistent drug pricing issue are anticipated to affect the stock." (10/16/2017)
  • 2. Jefferies Group LLC analysts commented, "We believe ESRX remains a Buy given our view that company fundamentals, including its FCF, are stable and that the stock's valuation is attractive at 9x FY18 P/E. That said, we recognize that headlines surrounding drug pricing pressure and the overhang from ESRX's Anthem contract will drive continued stock volatility NT." (2/17/2017)

Are investors shorting Express Scripts Holding Company?

Express Scripts Holding Company saw a increase in short interest during the month of September. As of September 29th, there was short interest totalling 32,966,022 shares, an increase of 3.9% from the September 15th total of 34,319,116 shares. Based on an average daily volume of 3,654,812 shares, the days-to-cover ratio is currently 9.0 days. Currently, 5.7% of the company's stock are short sold.

Who are some of Express Scripts Holding Company's key competitors?

Who owns Express Scripts Holding Company stock?

Express Scripts Holding Company's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Bridges Investment Management Inc. (0.01%), Eqis Capital Management Inc. (0.00%), First National Bank of Mount Dora Trust Investment Services (0.00%), Beacon Financial Group (0.00%), Osborn Williams & Donohoe LLC (0.00%) and Bridges Investment Counsel Inc. (0.00%). Company insiders that own Express Scripts Holding Company stock include Christopher A Mcginnis, Everett Neville, Mahon Thomas P Mac, Phyllis S Anderson and Woodrow A Myers Jr. View Institutional Ownership Trends for Express Scripts Holding Company.

Who sold Express Scripts Holding Company stock? Who is selling Express Scripts Holding Company stock?

Express Scripts Holding Company's stock was sold by a variety of institutional investors in the last quarter, including Bridges Investment Counsel Inc., First National Bank of Mount Dora Trust Investment Services and Bridges Investment Management Inc.. Company insiders that have sold Express Scripts Holding Company stock in the last year include Everett Neville, Phyllis S Anderson and Woodrow A Myers Jr. View Insider Buying and Selling for Express Scripts Holding Company.

Who bought Express Scripts Holding Company stock? Who is buying Express Scripts Holding Company stock?

Express Scripts Holding Company's stock was acquired by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc., Beacon Financial Group and Osborn Williams & Donohoe LLC. View Insider Buying and Selling for Express Scripts Holding Company.

How do I buy Express Scripts Holding Company stock?

Shares of Express Scripts Holding Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Express Scripts Holding Company's stock price today?

One share of Express Scripts Holding Company stock can currently be purchased for approximately $57.21.


MarketBeat Community Rating for Express Scripts Holding Company (NASDAQ ESRX)
Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  645 (Vote Outperform)
Underperform Votes:  431 (Vote Underperform)
Total Votes:  1,076
MarketBeat's community ratings are surveys of what our community members think about Express Scripts Holding Company and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Express Scripts Holding Company (NASDAQ:ESRX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Sell Ratings, 11 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.05)
Consensus Price Target: $68.50 (19.73% upside)
Consensus Price Target History for Express Scripts Holding Company (NASDAQ:ESRX)
Price Target History for Express Scripts Holding Company (NASDAQ:ESRX)
Analysts' Ratings History for Express Scripts Holding Company (NASDAQ:ESRX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/9/2017Raymond James Financial, Inc.Reiterated RatingMarket Perform -> UnderperformN/AView Rating Details
9/19/2017Royal Bank Of CanadaInitiated CoverageSector Perform -> Sector Perform$68.00HighView Rating Details
9/1/2017Robert W. BairdReiterated RatingHold$56.00MediumView Rating Details
8/29/2017Jefferies Group LLCSet Price TargetBuy$72.00LowView Rating Details
8/10/2017Morgan StanleyBoost Price TargetUnderweight$52.00 -> $57.00LowView Rating Details
7/21/2017Needham & Company LLCInitiated CoverageHold -> HoldLowView Rating Details
6/9/2017Cowen and CompanyReiterated RatingOutperform$83.00LowView Rating Details
4/26/2017Evercore ISILower Price TargetIn-Line$68.50 -> $59.00MediumView Rating Details
4/26/2017Edward JonesDowngradeBuy -> HoldHighView Rating Details
4/25/2017SunTrust Banks, Inc.Reiterated RatingBuyHighView Rating Details
4/25/2017Bank of America CorporationReiterated RatingNeutral$77.00HighView Rating Details
4/25/2017MizuhoLower Price TargetNeutral -> Neutral$76.00 -> $61.00HighView Rating Details
3/29/2017ArgusReiterated RatingHoldLowView Rating Details
3/15/2017Wells Fargo & CompanyDowngradeMarket Perform -> UnderperformLowView Rating Details
3/8/2017Leerink SwannReiterated RatingMarket Perform$75.00LowView Rating Details
2/16/2017Credit Suisse GroupReiterated RatingBuy$85.00N/AView Rating Details
2/14/2017Oppenheimer Holdings, Inc.Reiterated RatingHoldN/AView Rating Details
12/16/2016Barclays PLCReiterated RatingOverweightN/AView Rating Details
12/1/2016Sanford C. BernsteinReiterated RatingUnderperform$59.00N/AView Rating Details
11/3/2016Deutsche Bank AGUpgradeSell -> Hold$69.00 -> $70.00N/AView Rating Details
6/1/2016WedbushReiterated RatingNeutralN/AView Rating Details
5/24/2016Citigroup Inc.Reiterated RatingBuyN/AView Rating Details
4/27/2016FBR & CoLower Price TargetMkt Perform$90.00 -> $75.00N/AView Rating Details
3/18/2016William BlairReiterated RatingBuyN/AView Rating Details
2/18/2016Goldman Sachs Group, Inc. (The)Lower Price TargetNeutral$82.00 -> $74.00N/AView Rating Details
2/17/2016Maxim GroupReiterated RatingBuy$109.00 -> $95.00N/AView Rating Details
12/23/2015BMO Capital MarketsBoost Price TargetMarket Perform$94.00N/AView Rating Details
11/29/2015J P Morgan Chase & CoReiterated RatingBuy$105.00N/AView Rating Details
(Data available from 10/18/2015 forward)

Earnings

Earnings History for Express Scripts Holding Company (NASDAQ:ESRX)
Earnings by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Earnings History by Quarter for Express Scripts Holding Company (NASDAQ ESRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017$1.89N/AView Earnings Details
7/25/2017Q2 2017$1.71$1.73$25.52 billion$25.35 billionViewN/AView Earnings Details
4/24/2017Q1 17$1.32$1.33$24.95 billion$24.65 billionViewN/AView Earnings Details
2/14/2017Q4 2016$1.87$1.88$26.31 billion$24.90 billionViewListenView Earnings Details
10/25/2016Q3$1.74$1.74$25.48 billion$25.41 billionViewListenView Earnings Details
7/25/2016Q216$1.57$1.57$25.42 billion$25.20 billionViewListenView Earnings Details
4/25/2016Q1$1.22$1.22$25.20 billion$24.80 billionViewListenView Earnings Details
2/16/2016Q4$1.56$1.56$26.58 billion$26.18 billionViewListenView Earnings Details
10/27/2015Q315$1.44$1.45$26.38 million$25.22 millionViewListenView Earnings Details
7/28/2015Q215$1.40$1.44$26.13 billion$25.45 billionViewListenView Earnings Details
4/28/2015Q115$1.10$1.10$24.34 billion$24.90 billionViewListenView Earnings Details
2/23/2015Q414$1.38$1.39$25.68 billion$26.31 billionViewListenView Earnings Details
10/28/2014Q314$1.29$1.29$24.93 billion$25.78 billionViewListenView Earnings Details
7/29/2014Q214$1.22$1.23$24.42 billion$25.11 billionViewListenView Earnings Details
4/29/2014Q114$1.01$0.99$23.81 billion$23.69 billionViewListenView Earnings Details
2/20/2014Q413$1.12$1.12$25.49 billion$25.78 billionViewN/AView Earnings Details
10/25/2013Q313$1.08$1.08$25.01 billion$25.92 billionViewListenView Earnings Details
7/29/2013Q2 2013$1.10$1.12$25.51 billion$26.40 billionViewListenView Earnings Details
4/29/2013Q1 2013$0.97$0.99$25.55 billion$26.06 billionViewListenView Earnings Details
2/18/2013Q4 2012$1.04$1.05$27.24 billion$27.41 billionViewListenView Earnings Details
11/5/2012Q312$0.99$1.02$27.48 billion$27.00 billionViewN/AView Earnings Details
8/7/2012$0.82$0.88ViewN/AView Earnings Details
5/10/2012$0.77$0.73ViewN/AView Earnings Details
2/22/2012$0.85$0.82ViewN/AView Earnings Details
10/25/2011$0.77$0.79ViewN/AView Earnings Details
7/21/2011$0.69$0.71ViewN/AView Earnings Details
4/26/2011$0.69$0.66ViewN/AView Earnings Details
2/16/2011$0.70$0.71ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Express Scripts Holding Company (NASDAQ:ESRX)
2017 EPS Consensus Estimate: $6.98
2018 EPS Consensus Estimate: $7.63
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$1.31$1.33$1.32
Q2 20175$1.68$1.72$1.70
Q3 20175$1.90$1.91$1.90
Q4 20175$2.03$2.07$2.05
Q1 20184$1.45$1.52$1.49
Q2 20184$1.85$1.92$1.88
Q3 20184$2.02$2.09$2.05
Q4 20184$2.16$2.26$2.21
Q1 20191$1.59$1.59$1.59
Q2 20191$2.01$2.01$2.01
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Express Scripts Holding Company (NASDAQ:ESRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Express Scripts Holding Company (NASDAQ:ESRX)
Insider Ownership Percentage: 0.68%
Institutional Ownership Percentage: 88.69%
Insider Trades by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Institutional Ownership by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Insider Trades by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/11/2017Woodrow A Myers JrDirectorSell3,900$63.93$249,327.00View SEC Filing  
9/8/2017Phyllis S AndersonVPSell578$63.13$36,489.14View SEC Filing  
8/23/2017Everett NevilleVPSell1,163$61.48$71,501.24View SEC Filing  
5/19/2017Phyllis S AndersonVPSell1,100$60.08$66,088.00View SEC Filing  
3/1/2017Everett NevilleSVPSell2,352$70.16$165,016.32View SEC Filing  
1/3/2017Everett NevilleVPSell1,123$69.41$77,947.43View SEC Filing  
9/14/2016Woodrow A Myers JrDirectorSell12,036$70.40$847,334.40View SEC Filing  
9/12/2016Christopher A McginnisVPSell1,785$70.77$126,324.45View SEC Filing  
5/10/2016Everett NevilleVPSell800$74.11$59,288.00View SEC Filing  
4/29/2016Mahon Thomas P MacDirectorSell5,482$73.93$405,284.26View SEC Filing  
3/10/2016Christopher A McginnisVPSell579$68.56$39,696.24View SEC Filing  
3/7/2016Phyllis S AndersonVPSell614$71.14$43,679.96View SEC Filing  
2/29/2016Everett NevilleVPSell4,323$71.00$306,933.00View SEC Filing  
6/9/2015Gary WimberlyVPSell1,644$87.14$143,258.16View SEC Filing  
6/1/2015Gary WimberlyVPSell46,069$86.15$3,968,844.35View SEC Filing  
3/2/2015Glen D StettinVPSell2,674$84.39$225,658.86View SEC Filing  
2/25/2015Glen D StettinVPSell27,603$87.55$2,416,642.65View SEC Filing  
12/2/2014Keith J EblingVPSell10,000$84.25$842,500.00View SEC Filing  
12/1/2014Steven B MillerVPSell4,896$83.57$409,158.72View SEC Filing  
11/28/2014Glen D StettinVPSell10,800$82.96$895,968.00View SEC Filing  
11/17/2014John O ParkerDirectorSell25,822$78.75$2,033,482.50View SEC Filing  
11/7/2014Maura C BreenDirectorSell13,128$77.80$1,021,358.40View SEC Filing  
9/5/2014Edward B IgnaczakEVPSell9,886$75.28$744,218.08View SEC Filing  
8/28/2014Seymour SternbergDirectorSell15,508$74.12$1,149,452.96View SEC Filing  
8/25/2014Keith J EblingVPSell10,000$75.50$755,000.00View SEC Filing  
8/5/2014Gary G BenanavDirectorSell12,694$70.82$898,989.08View SEC Filing  
8/5/2014Sara E WadeVPSell20,000$70.44$1,408,800.00View SEC Filing  
8/4/2014David A NortonVPSell1,276$71.02$90,621.52View SEC Filing  
8/1/2014Maura C BreenDirectorSell12,694$69.94$887,818.36View SEC Filing  
6/13/2014George PazCEOSell681,508$71.21$48,530,184.68View SEC Filing  
3/11/2014Keith EblingVPSell25,721$78.69$2,023,985.49View SEC Filing  
3/10/2014Patrick McnameeCOOSell68,425$78.28$5,356,309.00View SEC Filing  
3/10/2014Steven MillerVPSell12,664$77.96$987,285.44View SEC Filing  
3/7/2014Keith EblingVPSell295,367$77.29$22,828,915.43View SEC Filing  
1/9/2014Nicholas LahowchicDirectorSell7,650$72.00$550,800.00View SEC Filing  
12/26/2013Nicholas LahowchicDirectorSell12,694$70.00$888,580.00View SEC Filing  
11/5/2013Mahon Thomas MacDirectorSell10,251$63.20$647,863.20View SEC Filing  
9/9/2013Maura C BreenDirectorSell10,527$64.12$674,991.24View SEC Filing  
9/4/2013Woodrow Myers, Jr.DirectorSell7,128$64.66$460,896.48View SEC Filing  
7/19/2013Nicholas LahowchicDirectorSell20,377$66.26$1,350,180.02View SEC Filing  
6/11/2013Woodrow A Myers JrDirectorSell1,750$62.57$109,497.50View SEC Filing  
5/28/2013Woodrow A Myers JrDirectorSell2,000$63.75$127,500.00View SEC Filing  
5/15/2013Jeffrey HallCFOSell13,307$61.13$813,456.91View SEC Filing  
5/8/2013Woodrow A Myers JrDirectorSell13,462$61.22$824,143.64View SEC Filing  
5/1/2013Keith J EblingEVPSell59,494$59.58$3,544,652.52View SEC Filing  
4/30/2013Patrick McnameeCOOSell271,972$59.65$16,223,129.80View SEC Filing  
3/14/2013Mahon Thomas P MacDirectorBuy5,000$59.58$297,900.00View SEC Filing  
9/4/2012Jeffrey HallCFOSell75,000$62.81$4,710,750.00View SEC Filing  
8/8/2012Edward B IgnaczakEVPSell115,466$59.33$6,850,597.78View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Express Scripts Holding Company (NASDAQ:ESRX)
Latest Headlines for Express Scripts Holding Company (NASDAQ:ESRX)
Source:
DateHeadline
nasdaq.com logoCompany Spotlight: Express Scripts
www.nasdaq.com - October 17 at 7:10 PM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - October 17 at 2:58 AM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Upgraded at Zacks Investment Research
www.americanbankingnews.com - October 16 at 2:56 PM
thestreet.com logoExpress Scripts to Acquire Medical Benefits Management Company - TheStreet.com
www.thestreet.com - October 15 at 10:40 PM
finance.yahoo.com logoExpress Scripts to Acquire Medical Benefits Management Company
finance.yahoo.com - October 15 at 5:38 PM
americanbankingnews.com logoFY2020 Earnings Estimate for Express Scripts Holding Company (ESRX) Issued By William Blair
www.americanbankingnews.com - October 13 at 4:20 PM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - October 12 at 3:16 PM
americanbankingnews.com logoWilliam Blair Weighs in on Express Scripts Holding Company's Q1 2018 Earnings (ESRX)
www.americanbankingnews.com - October 12 at 11:52 AM
streetinsider.com logoExpress Scripts (ESRX) to Acquire eviCore healthcare for $3.6B
www.streetinsider.com - October 11 at 7:56 PM
finance.yahoo.com logo[$$] Amazon Could Partner With Express Scripts
finance.yahoo.com - October 11 at 7:56 PM
finance.yahoo.com logoExpress Scripts Holding Co. – Value Analysis (NASDAQ:ESRX) : October 11, 2017
finance.yahoo.com - October 11 at 7:56 PM
finance.yahoo.com logoCareCore National, LLC -- Moody's places CareCore National's ratings on review for upgrade
finance.yahoo.com - October 11 at 7:56 PM
benzinga.com logoExpress Scripts: Another Potential Amazon Victim? - Benzinga
www.benzinga.com - October 11 at 2:15 AM
investorplace.com logoExpress Scripts Holding Company (ESRX) Buys eviCore Healthcare in $3.6B Deal - Investorplace.com
investorplace.com - October 11 at 2:15 AM
finance.yahoo.com logoExpress Scripts Holding Company -- Moody's affirms Express Scripts' Baa2 rating; stable outlook
finance.yahoo.com - October 10 at 9:12 PM
thestreet.com logoExpress Scripts Inks Deal to Buy EviCore for $3.6 billion
www.thestreet.com - October 10 at 4:10 PM
nasdaq.com logoExpress Scripts To Acquire EviCore Healthcare For $3.6 Bln - Quick Facts
www.nasdaq.com - October 10 at 4:10 PM
marketwatch.com logoUPDATE: Express Scripts shares drop 2.5% on $3.6 bln eviCore acquisition
www.marketwatch.com - October 10 at 4:10 PM
finance.yahoo.com logoExpress Scripts To Buy eviCore For $3.6B As Value-Based Care Takes Hold
finance.yahoo.com - October 10 at 4:10 PM
finance.yahoo.com logo[$$] Express Scripts to Buy eviCore for $3.6 Billion
finance.yahoo.com - October 10 at 4:10 PM
finance.yahoo.com logoExpress Scripts' Deal Helps Answer Amazon Threat
finance.yahoo.com - October 10 at 4:10 PM
finance.yahoo.com logoPharmacy benefit manager Express Scripts to buy eviCore for $3.6 bln
finance.yahoo.com - October 10 at 4:09 PM
finance.yahoo.com logoPharmacy benefit manager Express Scripts to buy eviCore for $3.6 billion
finance.yahoo.com - October 10 at 4:09 PM
finance.yahoo.com logoStocks Mixed but Gains in Walmart Push Dow Higher
finance.yahoo.com - October 10 at 4:09 PM
finance.yahoo.com logoExpress Scripts (ESRX) Dips on $3.6 Billion Deal to Buy EviCore Healthcare
finance.yahoo.com - October 10 at 4:09 PM
marketbeat.com logoExpress Scripts buying eviCore for $3.6 billion
marketbeat.com - October 10 at 9:41 AM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Earns "Underperform" Rating from Raymond James Financial, Inc.
www.americanbankingnews.com - October 9 at 8:54 AM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Stock Rating Lowered by UBS AG
www.americanbankingnews.com - October 9 at 8:17 AM
finance.yahoo.com logoAmazon Pharmacy Could Make Walgreens, CVS Sick
finance.yahoo.com - October 6 at 6:49 PM
finance.yahoo.com logoAnalyst: Amazon's Entry Into Pharmacy Is All But Certain At This Point
finance.yahoo.com - October 6 at 6:49 PM
investorplace.com logoStock of Express Scripts (ESRX) Ranked a Sell - Investorplace.com
investorplace.com - October 5 at 9:26 AM
finance.yahoo.com logoA New Normal? 870,000 Americans Used $50,000 Worth or More of Prescription Medicine in 2016
finance.yahoo.com - October 3 at 8:03 AM
nasdaq.com logoExpress Scripts Launches New Medicare Part D Saver Plan For 2018 - Quick Facts - Nasdaq
www.nasdaq.com - October 3 at 12:57 AM
finance.yahoo.com logoWhen Should You Buy Express Scripts Holding Company (ESRX)?
finance.yahoo.com - October 2 at 7:55 PM
americanbankingnews.com logo Brokerages Expect Express Scripts Holding Company (ESRX) to Announce $1.90 Earnings Per Share
www.americanbankingnews.com - October 2 at 4:18 PM
nasdaq.com logoIs Express Scripts Holding (ESRX) a Great Stock for Value Investors?
www.nasdaq.com - September 27 at 6:29 PM
finance.yahoo.com logoNovartis's $475,000 Price on Cancer Therapy Meets Resistance
finance.yahoo.com - September 22 at 8:23 AM
finance.yahoo.com logoExpress Scripts Holding Co. breached its 50 day moving average in a Bearish Manner : ESRX-US : September 19, 2017
finance.yahoo.com - September 19 at 6:23 PM
americanbankingnews.com logoRoyal Bank Of Canada Begins Coverage on Express Scripts Holding Company (ESRX)
www.americanbankingnews.com - September 19 at 7:38 AM
americanbankingnews.com logoResearch Analysts Issue Forecasts for Express Scripts Holding Company's Q1 2019 Earnings (ESRX)
www.americanbankingnews.com - September 18 at 8:00 AM
finance.yahoo.com logoWhy Express Scripts Holding Company (ESRX) Could Be A Buy
finance.yahoo.com - September 17 at 10:47 PM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - September 17 at 1:20 PM
americanbankingnews.com logo$25.67 Billion in Sales Expected for Express Scripts Holding Company (ESRX) This Quarter
www.americanbankingnews.com - September 15 at 5:40 AM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) VP Sells $36,489.14 in Stock
www.americanbankingnews.com - September 12 at 8:24 PM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Director Sells $249,327.00 in Stock
www.americanbankingnews.com - September 12 at 7:52 PM
finance.yahoo.com logoExpress Scripts Offers Important Prescription Drug Information for Residents Impacted by Hurricane Irma
finance.yahoo.com - September 7 at 6:31 PM
finance.yahoo.com logoExpress Scripts Holding Company Announces Third Quarter 2017 Earnings Conference Call
finance.yahoo.com - September 5 at 8:04 PM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Receives "Hold" Rating from Robert W. Baird
www.americanbankingnews.com - September 1 at 8:56 PM
finance.yahoo.com logoExpress Scripts Holding Co. breached its 50 day moving average in a Bullish Manner : ESRX-US : September 1, 2017
finance.yahoo.com - September 1 at 6:44 PM
barrons.com logoLoews Invests $21M in CVS; Tisch Buys GE - Barron's
www.barrons.com - August 30 at 7:42 PM

Social

Chart

Express Scripts Holding Company (ESRX) Chart for Wednesday, October, 18, 2017

This page was last updated on 10/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.